FDA reviewers found no human clinical studies supporting its proposed wound-healing uses
Myara I, Alamowitch C, Michel O, Heudes D, Bariety J, Guy-Grand B et al
Cysteine availability, in particular, can be a limiting factor for glutathione production
But the payoff is less chair time for the patient, fewer appointments overall per case, and a better treatment outcome
It also turns out that females who only carry one copy of a G6PD mutation also have partial protection from severe malaria.[ref] Here are a few examples of population frequencies of G6PD deficiency (including mild and severe): Guangxi, China 7%[ref] Sardinia 12%[ref] India 8% (varies from 0 27% depending on the ethnic group)[ref] S.E
What biomarkers reliably measure senescent cell clearance in humans